Cite
miR-4324 inhibits ovarian cancer progression by targeting FEN1.
MLA
Wu, Haixia, et al. “MiR-4324 Inhibits Ovarian Cancer Progression by Targeting FEN1.” Journal of Ovarian Research, vol. 15, no. 1, Mar. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13048-022-00959-5.
APA
Wu, H., Yan, Y., Yuan, J., Luo, M., & Wang, Y. (2022). miR-4324 inhibits ovarian cancer progression by targeting FEN1. Journal of Ovarian Research, 15(1), 1–10. https://doi.org/10.1186/s13048-022-00959-5
Chicago
Wu, Haixia, Youliang Yan, Jialin Yuan, Mengze Luo, and Yingjian Wang. 2022. “MiR-4324 Inhibits Ovarian Cancer Progression by Targeting FEN1.” Journal of Ovarian Research 15 (1): 1–10. doi:10.1186/s13048-022-00959-5.